Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew Genet

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Seminars in Interventional Radiology|November 21, 2022
Antithrombotic Therapy after Deep Venous InterventionNicholas Xiao, Matthew Genet, Minhaj Khaja, et al.
Phlebology|February 12, 2024
The clinical and economic impact of chronic venous insufficiency-associated lymphedema and the prevalence of persistent edema after venous interventionMatthew Genet, Nicos Labropoulos, Antonios Gasparis, et al.
CVIR Endovascular|April 2, 2024
Single-procedure 8Fr rheolytic pharmacomechanical thrombectomy for treatment of acute iliofemoral deep venous thrombosisNicholas Xiao, Matthew Genet, Rocio Marquez Karry, et al.
Neuroscience Letters|August 6, 2016
Advanced age negatively impacts survival in an experimental brain tumor modelErik Ladomersky, Lijie Zhai, Galina Gritsina, et al.
Immunotherapy (Los Angeles, Calif.)|November 8, 2016
The Kynurenine/Tryptophan Ratio and Glioblastoma Patients Treated with Hsppc-96 VaccineAlicia Lenzen, Lijie Zhai, Kristen L Lauing, et al.
Oncoimmunology|September 14, 2016
Improving vaccine efficacy against malignant gliomaErik Ladomersky, Matthew Genet, Lijie Zhai, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 29, 2017
Infiltrating T Cells Increase IDO1 Expression in Glioblastoma and Contribute to Decreased Patient SurvivalLijie Zhai, Erik Ladomersky, Kristen L Lauing, et al.
Oncotarget|May 29, 2018
Indoleamine 2,3-dioxygenase 1 and overall survival of patients diagnosed with esophageal cancerAri J Rosenberg, Derek A Wainwright, Alfred Rademaker, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 4, 2021
Tumor Cell IDO Enhances Immune Suppression and Decreases Survival Independent of Tryptophan Metabolism in GlioblastomaLijie Zhai, April Bell, Erik Ladomersky, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Seminars in Interventional Radiology|November 21, 2022
Antithrombotic Therapy after Deep Venous InterventionNicholas Xiao, Matthew Genet, Minhaj Khaja, et al.
Phlebology|February 12, 2024
The clinical and economic impact of chronic venous insufficiency-associated lymphedema and the prevalence of persistent edema after venous interventionMatthew Genet, Nicos Labropoulos, Antonios Gasparis, et al.
CVIR Endovascular|April 2, 2024
Single-procedure 8Fr rheolytic pharmacomechanical thrombectomy for treatment of acute iliofemoral deep venous thrombosisNicholas Xiao, Matthew Genet, Rocio Marquez Karry, et al.
Neuroscience Letters|August 6, 2016
Advanced age negatively impacts survival in an experimental brain tumor modelErik Ladomersky, Lijie Zhai, Galina Gritsina, et al.
Immunotherapy (Los Angeles, Calif.)|November 8, 2016
The Kynurenine/Tryptophan Ratio and Glioblastoma Patients Treated with Hsppc-96 VaccineAlicia Lenzen, Lijie Zhai, Kristen L Lauing, et al.
Oncoimmunology|September 14, 2016
Improving vaccine efficacy against malignant gliomaErik Ladomersky, Matthew Genet, Lijie Zhai, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 29, 2017
Infiltrating T Cells Increase IDO1 Expression in Glioblastoma and Contribute to Decreased Patient SurvivalLijie Zhai, Erik Ladomersky, Kristen L Lauing, et al.
Oncotarget|May 29, 2018
Indoleamine 2,3-dioxygenase 1 and overall survival of patients diagnosed with esophageal cancerAri J Rosenberg, Derek A Wainwright, Alfred Rademaker, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 4, 2021
Tumor Cell IDO Enhances Immune Suppression and Decreases Survival Independent of Tryptophan Metabolism in GlioblastomaLijie Zhai, April Bell, Erik Ladomersky, et al.
Pageof 1